Kenox Pharmaceuticals is a contract development, manufacturing, and testing organization (CDMO) specializing in nasal, inhalation, and ophthalmic drug products. We provide end-to-end support from early-stage R&D through GMP fill-finish and testing for both non-sterile and sterile drug-device combination products intended for Phase I and II clinical trials. Our strength lies in our deep scientific expertise, broad development experience, and flexible approach to managing diverse delivery platforms—including Soft Mist Inhalers—to enable innovative and effective drug delivery solutions. We also have preIND-stage nasal and soft mist inhalation assets open for collaboration and partnering.